// company-profile
Outlook Therapeutics, Inc.
OTLK// activity-summary
Recent insider activity is bullish. Over the last 30 days, 9 insiders purchased shares (net $5.3M). Buying was led by Sukhtian Ghiath M..
// 90-day insight
Over the last 90 days, Outlook Therapeutics, Inc. insiders bought $5.3M across 9 transactions with no open-market sales.
- Most active insider: Sukhtian Ghiath M. with 7 transactions totaling $5.0M.
- Largest single purchase: $5.0M by Sukhtian Ghiath M. on May 28, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Outlook Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Haddadin Yezan Munther | OTLK | Purchase | 29,000 | $0.83 | $24K |
| May 28, 2026 | Sukhtian Ghiath M. | OTLK | Purchase | 8,571,428 | — | — |
| May 28, 2026 | Sukhtian Ghiath M. | OTLK | Purchase | 8,539,709 | $0.59 | $5.00M |
| May 28, 2026 | Sukhtian Ghiath M. | OTLK | H | 3,458,571 | — | — |
| May 28, 2026 | Sukhtian Ghiath M. | OTLK | Purchase | 3,458,571 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.